Planta Med 2010; 76 - P426
DOI: 10.1055/s-0030-1264724

Anti-adhesive activity of extracts from edible and medicinal mushrooms against Campylobacter jejuni

J Chamiolo 1, D Oehrke 1, K Schmidt 1, K Bensch 1, J Tiralongo 1, U Lindequist 2, E Tiralongo 3
  • 1Griffith University, School of Pharmacy, Gold Coast Campus, 4222 Gold Coast, Australia
  • 2Ernst-Moritz-Arndt-University Greifswald, Institute of Pharmacy, F.-L.-Jahn-Str. 17, 17489 Greifswald, Germany
  • 3Griffith University, School of Pharmacy & Griffith Institute of Health Medical Research, Gold Coast Campus, 4222 Gold Coast, Australia

Campylobacter jejuni is one of the most common bacterial causes of diarrhoea in the industrialised world [1], being associated with the occurrence of Guillain-Barré Syndrome (GBS) [2] and induces diseases partially through intestinal adherence [3]. With increasing reports of C. jejuni drug resistance against standard antibiotics [4] investigations into anti-adhesive agents for the prevention of bacterial infection [5] are highly significant, particularly given the possibility of avoiding resistance [6]. Different studies have shown anti-adhesive activity of different plant compounds against a variety of bacteria including C. jejuni [5]. Although two studies report on anti-adhesive effects of fungal compounds/extracts against yeast [7] and virus [8], this is the first study that describes anti-adhesive effects of basidiomycetes against any bacteria. Nineteen extracts from 9 edible and medicinal mushroom species (Calvatia gigantea, Flammulina velutipes, Inonotus obliquus, Inonotus hispidus, Inonotus nodulosus, Inonotus dryadeus, Ganoderma lucidum, Ganoderma pfeifferi, Piptoporus betulinus) were screened for anti-adhesive activity against C. jejuni using modifications of previously published anti-adhesion assays [9, 10]. The 2 ethanolic extracts derived from the fruiting bodies of Inonotus nodulosus and Inonotus obliquus showed high anti-adhesive activity (IC50 0.017mg/mL and IC50 0.021mg/mL, respectively). Moreover, the methanolic extracts of the fruiting bodies of Calvatia gigantea and Piptoporus betulinus showed, although not dose dependent, high anti-adhesive activity (81%±13% and 71%±10%, respectively) at 0.002mg/mL. Further investigations need to be conducted to evaluate whether isolated compounds would be candidates for the development of novel drugs against bacterial adhesion.

References: 1. Young KT et al. Nat Rev Microbiol, 2007. 5(9): p.665–79.

2. Mishu, B. et al. Clin Infect Dis, 1993. 17(1): p.104–8.

3. Park, S.F., Int J Food Microbiol, 2002. 74(3): p.177–88.

4. Allos, B.M., Clin Infect Dis, 2001. 32(8): p.1201–6.

5. Wittschier, N., et al., J Pharm Pharmacol, 2007. 59(6): p.777–86.

6. Brown, E.D. et al., Chem Rev, 2005. 105(2): p.759–74.

7. Falkensammer, B., et al., Mycoses, 2008. 51(6): p.505–514.

8. Eo, S.K., et al., J. Ethnopharmacol., 2000. 72(3): p.475–481.

9. Beil, W. et al. Phytomedicine, 2007. 14 Suppl 6: p.5–8.

10. O'Mahony, R., et al., World J Gastroenterol, 2005. 11(47): p.7499–507.